no additional AEs/No other information provided; Caller reports adult formulation of RECOMBIVAX HB was administered to a 18 year old female. No other information provided. No additional AEs/PQC reported. Caller declined AE follow up letter.; This spontaneous report was received from a pharmacist and referred to an 18-year-old female patient. The patient’s concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported. On 15-JAN-2025, the patient was vaccinated adult formulation with hepatitis b vaccine (recombinant) (RECOMBIVAX HB), 10 Microgram/1.0 ml intramuscular injection, 1.0 ml, administered intramuscularly for prophylaxis (lot #, anatomical site of administration and expiry date were not provided) (overdose) by Health Professional. No other information provided. No additional adverse events (AEs). Additional Information is not expected.